UBS Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-7,699
| Closed | -$146K | – | 7468 |
|
|
2019
Q1 | $146K | Buy |
7,699
+1,482
| +24% | +$28.1K | ﹤0.01% | 4048 |
|
|
2018
Q4 | $84K | Hold |
6,217
| – | – | ﹤0.01% | 4808 |
|
|
2018
Q3 | $69K | Buy |
+6,217
| New | +$69K | ﹤0.01% | 5030 |
|
|
2017
Q1 | – | Sell |
-5,694
| Closed | -$28K | – | 7175 |
|
|
2016
Q4 | $28K | Buy |
5,694
+1,944
| +52% | +$9.56K | ﹤0.01% | 5369 |
|
|
2016
Q3 | $19K | Sell |
3,750
-743
| -17% | -$3.77K | ﹤0.01% | 5467 |
|
|
2016
Q2 | $23K | Sell |
4,493
-91
| -2% | -$466 | ﹤0.01% | 5324 |
|
|
2016
Q1 | $27K | Sell |
4,584
-121
| -3% | -$713 | ﹤0.01% | 5176 |
|
|
2015
Q4 | $49K | Buy |
4,705
+1,569
| +50% | +$16.3K | ﹤0.01% | 4776 |
|
|
2015
Q3 | $58K | Buy |
3,136
+436
| +16% | +$8.06K | ﹤0.01% | 4608 |
|
|
2015
Q2 | $53K | Sell |
2,700
-4,959
| -65% | -$97.3K | ﹤0.01% | 4752 |
|
|
2015
Q1 | $134K | Buy |
7,659
+3,659
| +91% | +$64K | ﹤0.01% | 4027 |
|
|
2014
Q4 | $64K | Buy |
+4,000
| New | +$64K | ﹤0.01% | 4537 |
|